Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Ostend – page 2

28 clinical trials in Ostend, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Ostend at a glance
28
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

28 trials in Ostend

Open in trial search
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:ABBV-8736
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.

Disease risk factor+1

Not yet recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Hamilton Health Sciences Corporation

Type 2 diabetes mellitus

Not yet recruiting
Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Bromocriptine
  • Sponsor:Eli Lilly Cork Limited
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Eli Lilly & Co.

Ischaemic stroke

Not yet recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Redasemtide
  • Sponsor:Shionogi B.V.

Ischaemic stroke+2

Not recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Asundexian
  • Sponsor:Bayer AG
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Macrogol 4000
  • Sponsor:Ntc S.r.l.
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Entecavir
  • Sponsor:Antwerp University Hospital
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Pfizer Inc.
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Infliximab
  • Sponsor:Belgian IBD Research and Development

Other cities in Belgium

The busiest research cities in the country

All 170 cities in Belgium

Clinical research in Ostend

What the registry says about research in the country

01 Gastroenterology Research

Innovative studies focusing on chronic hepatitis B treatment optimization and management of Crohn's disease recurrence after surgery. Research includes evaluation of medication interruption strategies and postoperative therapeutic approaches.

  • Hepatitis B Treatment Cessation
  • Inflammatory Bowel Disease Management
  • Postoperative Crohn's Disease Care

Studies also examine subcutaneous treatment options for various inflammatory bowel conditions.

02 Cardiovascular Studies

Advanced research investigating mechanical valve treatments and stroke prevention strategies. Clinical trials are evaluating new anticoagulation approaches and innovative therapies for post-stroke care.

  • Mechanical Valve Management
  • Stroke Prevention
  • Anticoagulation Optimization

These studies aim to improve patient outcomes in cardiovascular care and stroke management.

03 Oncology Research

Comprehensive studies in advanced cancer treatments, including trials for prostate, breast, and ovarian cancers. Research focuses on biomarker-driven therapies and innovative treatment combinations.

  • Prostate Cancer Biomarkers
  • Advanced Breast Cancer Therapy
  • Ovarian Cancer Treatment

Investigation of personalized treatment approaches based on molecular characteristics.

04 Metabolic Disorders

Groundbreaking research on Type 2 Diabetes management and obesity treatment. Studies evaluate new therapeutic options and medication switching strategies.

  • Diabetes Management
  • Weight Management Solutions
  • Cardiovascular Risk Reduction

Focus on comparing treatment efficacy and optimizing patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.